Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-23-002788
Filing Date
2023-01-13
Accepted
2023-01-13 16:10:36
Documents
7
Period of Report
2023-01-13

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea171604-6k_canfitebio.htm 6-K 16095
2 NOTICE AND PROXY STATEMENT WITH RESPECT TO THE COMPANY'S SPECIAL GENERAL MEETING ea171604ex99-1_canfitebio.htm EX-99.1 220530
3 PROXY CARD FOR HOLDERS OF ORDINARY SHARES WITH RESPECT TO THE COMPANY'S SPECIAL ea171604ex99-2_canfitebio.htm EX-99.2 14945
4 VOTING INSTRUCTION CARD FOR AMERICAN DEPOSITARY SHAREHOLDERS WITH RESPECT TO THE ea171604ex99-3_canfitebio.htm EX-99.3 2187
5 GRAPHIC ex99-1_001.jpg GRAPHIC 4470
6 GRAPHIC ex99-3_001.jpg GRAPHIC 420858
7 GRAPHIC ex99-3_002.jpg GRAPHIC 502080
  Complete submission text file 0001213900-23-002788.txt   1532356
Mailing Address 10 BAREKET STREET, KIRYAT MATALON P.O. BOX 7537 PETACH TIKVA L3 4951778
Business Address 10 BAREKET STREET, KIRYAT MATALON P.O. BOX 7537 PETACH TIKVA L3 4951778 972 39241114
Can-Fite BioPharma Ltd. (Filer) CIK: 0001536196 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36203 | Film No.: 23528886
SIC: 2834 Pharmaceutical Preparations